Hyperpigmentation Treatment Market Size, Share & Trends Analysis Report By Indication (Age Spots, Melasma), By Treatment (Chemical Peel, Energy-based, Microdermabrasion), By Skin Tone, By End-use, By Region, And Segment Forecasts, 2024 - 2030

Hyperpigmentation Treatment Market Trends

The global hyperpigmentation treatment market size was estimated at USD 1.3 billion in 2023 and is expected to grow at a CAGR of 6.4% from 2024 to 2030. The market is driven by a growing societal emphasis on skin health and appearance, driving individuals to seek treatments for hyperpigmentation. Additionally, advancements in aesthetic technologies and procedures, such as laser therapy, chemical peels, and microneedling, are making treatments more effective and accessible. The rise in disposable income and the increasing affordability of aesthetic procedures are also contributing to market growth. Furthermore, the availability of a wide range of treatment options and the expansion of dermatology clinics and aesthetic centres globally are further fuelling the market expansion.

The market is also being driven by the growing elderly population, which is particularly vulnerable to hyperpigmentation.The prevalence of hyperpigmentation in the geriatric population is primarily due to prolonged sun exposure over the years, leading to age spots and uneven skin tone. Additionally, age-related hormonal changes and a decrease in skin regeneration contribute to the development and persistence of hyperpigmentation in older adults. According to the World Health Organization, the elderly population (above 60 years) is expected to reach 2.1 billion by 2050, representing a significant opportunity for growth in the hyperpigmentation treatment market. The aging population is seeking effective treatments for skin discoloration, which is driving innovation and adoption of advanced therapies.

Moreover, the hyperpigmentation treatment market is experiencing growth due to heightened awareness about skincare and a rising demand for innovative solutions. According to a 2022 report by the National Library of Medicine, the importance of skincare significantly increased during the pandemic, while makeup usage declined. Consumers are now more inclined to seek specialized treatments, including topical creams, serums, chemical peels, and laser therapies, to address dark spots, achieve an even skin tone, and restore radiance. Additionally, the expansion of skincare brands and clinics offering these specialized treatments has further fuelled market growth.

The market is anticipated to grow due to technological advancements in hyperpigmentation treatment products. For instance, in March 2020, SkinCeuticals' introduced its 15% TCA (trichloroacetic acid) Peel. This professional chemical peel, designed for in-office use, provides precise application with consistent delivery and predictable results, boasting a 19% improvement in hyperpigmentation appearance. These innovative products enhance the effectiveness and safety of hyperpigmentation treatments, appealing to a wider consumer base and driving market growth.

Market Concentration & Characteristics

The hyperpigmentation treatment market is highly fragmented, indicating a limited number of major players dominating the industry. This fragmentation suggests a competitive landscape where key companies are vying to hold significant market share and establish their brand presence through extensive research and development capabilities and elongated service offerings.

The market is witnessing ongoing research and development activities driven by the increasing prevalence of pigmentation disorders and the need for effective therapies. Major market players are investing in R&D initiatives to develop innovative treatments, such as drug therapies for conditions like vitiligo, and exploring the use of corticosteroids for treating pigmentation disorders.

The market has recently seen a surge in merger and acquisition (M&A) activities, for instance in December 2021, DermBiont, Inc., a clinical-stage biotech firm specializing in targeted topical therapeutics for skin diseases, completed a $28 million Series A2 funding round alongside the acquisition of Chromaderm, another clinical-stage biotech company. This strategic move aims to bolster DermBiont's portfolio with Chromaderm's innovative topical melanin inhibitor, marking a significant step towards advancing first-in-class treatments for skin brightening, melasma, and other melanin-related skin conditions.

The regulatory scenario in the global market is complex and varies by region. In the U.S., the Food and Drug Administration (FDA) regulates hyperpigmentation treatment products as cosmetics or drugs, depending on their intended use and ingredients. In Europe, the European Medicines Agency (EMA) and the European Commission regulate these products under the European Union's (EU) cosmetics and pharmaceutical legislation. In Asia, regulations vary by country, with some following the Association of Southeast Asian Nations (ASEAN) guidelines for cosmetics and pharmaceuticals.

Major players in the global hyperpigmentation treatment market are actively pursuing market expansion strategies. For instance, in March 2021, Colorescience, renowned for its dermatologist-endorsed specialty skincare and cosmetics announced the expansion of its best-selling Even Up series, specifically targeting hyperpigmentation treatments. This move underscores the brand's commitment to providing innovative solutions for skin discoloration, catering to the growing demand for effective hyperpigmentation products.

Indication Insights

The age spots segment dominated the market and held the largest revenue share of over 36.56% in 2023. Age spots, also known as liver spots or solar lentigines, are caused by prolonged sun exposure and the natural aging process, leading to hyperpigmentation in older adults. The increasing prevalence of these age-related skin conditions among the aging population is a key driver of this segment. An important fact is that approximately 90% of individuals over the age of 60 exhibit some form of age spots. Rising awareness and demand for aesthetic treatments, along with advancements in dermatological procedures, have further bolstered the segment's growth.

The melasma segment is expected to grow at the fastest CAGR of 7.1% from 2024 to 2030. The rising incidence of melasma, particularly among women, is driving a growing demand for effective treatment options. This demand is further fuelled by increasing awareness about skin health and the availability of advanced treatment modalities, such as laser therapy and chemical peels. A notable example is a study published in Dermatology Times in June 2023, which highlighted the promising results of microneedling combined with glutathione in the treatment of melasma. This innovative approach has shown significant efficacy, adding to the array of advanced treatments available for this condition.

As the demand for aesthetic treatments continues to rise, the melasma segment is poised for significant expansion in the coming years. The combination of increased awareness, advancements in treatment options, and the ongoing development of new therapeutic approaches are expected to drive sustained growth in the melasma treatment market. This trend underscores the broader movement towards personalized and effective skincare solutions, reflecting a shift in consumer preferences and technological progress in dermatology.

Treatments Insights

The energy-based therapy segment dominated the market and held the largest revenue share of over 68.30% in 2023. This significant market share can be attributed to the growing popularity and effectiveness of treatments such as laser therapy, intense pulsed light (IPL), and radiofrequency (RF) in managing hyperpigmentation. Advancements in these technologies have led to safer, more efficient, and minimally invasive procedures, appealing to a broad range of patients seeking cosmetic improvements.

Additionally, rising consumer awareness about aesthetic treatments and increasing disposable incomes have further propelled the demand for energy-based therapies. The availability of skilled professionals and continuous innovation in energy-based devices also contribute to the segment's dominance in the global market.

The microneedling segment is expected to grow at the fastest CAGR of 6.7% from 2024 to 2030. This growth is driven due to their effectiveness in treating various skin conditions, including hyperpigmentation. The procedure's minimally invasive nature, coupled with its ability to stimulate collagen production and enhance skin texture, has made it a popular choice among patients and dermatologists alike. Recent innovations, such as the combination of microneedling with topical agents like glutathione, have shown promising results in improving treatment outcomes, further boosting the segment's growth. Additionally, the rising demand for non-surgical aesthetic treatments and the growing consumer awareness about advanced skincare options are expected to contribute significantly to the expansion of the microneedling segment in the global hyperpigmentation treatment market.

Skin Tone Insights

The Fitzpatrick skin type III & IV segment dominated the market and held the largest revenue share of over 39.6% in 2023. This dominance is attributed to the higher prevalence of hyperpigmentation disorders in individuals with these skin types. The Fitzpatrick skin type III is characterized by light brown skin that tans easily and rarely burns, while type IV is characterized by moderate brown skin that rarely burns and tans easily. These skin types are more prevalent in populations from Asia, Latin America, and the Mediterranean, where hyperpigmentation disorders such as melasma and post-inflammatory hyperpigmentation are common. Additionally, the increasing awareness and understanding of hyperpigmentation therapeutic interventions, as well as the availability of advanced treatment options, have contributed to the growth of this segment.

The Fitzpatrick skin type V & VI segment is expected to grow at the fastest CAGR of 6.8% from 2024 to 2030. This growth is driven by the increasing recognition of the unique dermatological needs of individuals with darker skin tones, who are more prone to hyperpigmentation issues such as melasma and post-inflammatory hyperpigmentation. The rising availability and development of specialized treatments and products tailored for these skin types are also contributing to the segment's expansion. Innovations in laser technologies and skincare formulations that are safe and effective for darker skin tones are gaining popularity. Additionally, the growing awareness and demand for inclusive and diverse skincare solutions, coupled with increasing disposable incomes in emerging markets, are expected to further propel the growth of the Fitzpatrick skin type V & VI segment in the global market.

End-use Insights

The dermatology clinics segment dominated the market with a revenue share of over 49.4% in 2023. This dominance is attributed to the high level of trust and expertise associated with dermatology clinics, making them the preferred choice for patients seeking professional and effective hyperpigmentation treatments. Dermatology clinics offer a wide range of advanced treatment options, including laser therapies, chemical peels, and microneedling. The availability of personalized treatment plans and comprehensive follow-up care at these clinics further enhances patient outcomes and satisfaction. Additionally, the increasing prevalence of skin disorders, growing awareness about skin health, and rising demand for cosmetic dermatology services have significantly boosted the revenue share of dermatology clinics in the global hyperpigmentation treatment market.

In the market, the dermatology clinics segment shows significant variations in market size across different countries. The U.S. holds a substantial share with nearly 12,040 dermatologists and a comparatively higher number of dermatologists per million patients; in addition, China has nearly 30,000 dermatologists with sub-par distribution. These figures reflect the growing global emphasis on dermatological treatments for hyperpigmentation, driven by increasing awareness and demand for such procedures.

The aesthetic center segment is expected to grow at the fastest CAGR of 6.8% from 2024 to 2030. This growth is driven by the increasing demand for non-invasive and minimally invasive cosmetic procedures to treat hyperpigmentation. Aesthetic centres, known for offering a wide range of advanced treatments such as chemical peels, laser therapies, and microdermabrasion, are becoming increasingly popular among patients seeking effective and convenient skincare solutions. The rise in disposable incomes, greater awareness of aesthetic treatments, and the growing trend towards maintaining youthful and healthy skin are further propelling the segment's expansion.

Regional Insights

North America hyperpigmentation treatment market held the largest revenue share of 53.85% in 2023 due to the region's advanced healthcare infrastructure, high adoption rate of innovative medical technologies, and increasing consumer awareness about skin health. The presence of key market players and a significant number of dermatology clinics and aesthetic centres offering a wide range of hyperpigmentation treatment options also contribute to North America's dominance. Additionally, the region's strong emphasis on cosmetic procedures, coupled with a higher disposable income among the population, drives the demand for hyperpigmentation treatments. The growing prevalence of skin conditions and the increasing focus on skincare further bolster the market in North America.

U.S. Hyperpigmentation Treatment Market Trends

The U.S. hyperpigmentation treatment market accounted revenue share of 90.62% in 2023 due to factors such as a large population seeking aesthetic treatments, high disposable income, advanced healthcare infrastructure, and a strong presence of key market players. Additionally, the increasing awareness about skin health and beauty standards in the U.S. contributes to the market's growth.

The hyperpigmentation treatment market in Mexico is expected to witness lucrative growth from 2024 to 2030, driven by factors such as a rising middle-class population, increasing disposable income, and growing awareness about skincare and aesthetic treatments. Additionally, the availability of advanced treatment options and the presence of skilled dermatologists contribute to the market's expansion in Mexico.

Europe Hyperpigmentation Treatment Market Trends

Europe hyperpigmentation treatment market is showing lucrative growth due to the high prevalence of pigmentation disorders among the aging population, especially those aged 65 and above, who constitute one of the world's oldest demographics. This demographic factor, combined with the region's advanced healthcare infrastructure and the presence of major market players offering effective treatment options, positions Europe as a key driver of growth in the global hyperpigmentation treatment market.

The hyperpigmentation treatment market in the Germany showed dominance with the highest revenue share of 20.62% in 2023. Germany has an advanced healthcare system, high consumer awareness about skincare, and the availability of a wide range of treatment options, including both medical procedures and over-the-counter products. The market's success in Germany can also be attributed to the growing demand for aesthetic treatments among the population, driven by societal pressures and the desire for clear, blemish-free skin.

France hyperpigmentation treatment market held the second-largest market share in 2023. The market is driven by the high standard of healthcare infrastructure, a well-established cosmetic industry, and a growing preference for advanced skincare solutions among the population. Additionally, the presence of leading dermatology clinics and aesthetic centres offering innovative treatment options contributes to the market's growth in Germany.

Asia Pacific Hyperpigmentation Treatment Market Trends

The hyperpigmentation treatment market in Asia Pacific is expected to witness the fastest CAGR of 8.3% from 2024 to 2030. This growth is driven by the increasing prevalence of hyperpigmentation disorders, rising awareness about skincare, and growing demand for cosmetic treatments in countries such as China, India, and Japan. Furthermore, the presence of a large patient pool, improving healthcare infrastructure, and increasing disposable incomes are also expected to drive the growth of the hyperpigmentation treatment market in the Asia Pacific region.

The hyperpigmentation treatment market in Japan held the largest revenue market share of 25.60% in 2023 due to the country's significant focus on research and development, increased demand for cosmetic treatments, and a large patient population. The market growth is driven by the availability of advanced treatment options, growing awareness about skincare, and improving healthcare infrastructure. Additionally, the country's large population and increasing disposable incomes have contributed to the growth of the hyperpigmentation treatment market.

China hyperpigmentation treatment market held the second largest market share in the Asia Pacific region. This is due to the strong focus on skincare and beauty, technological advancements in treatment options, and a well-developed healthcare infrastructure. The market benefits from a high level of consumer awareness about hyperpigmentation and a willingness to invest in effective treatments. Additionally, the presence of leading dermatological clinics and aesthetic centres offering a wide range of advanced treatments further propels the market in China.

The hyperpigmentation treatment market in India is anticipated to witness a CAGR of 9.0% from 2024 to 2030. This is due to the increasing urbanization and changing lifestyles in the country have led to higher exposure to environmental stressors, contributing to the prevalence of pigmentation disorders. Coupled with this, the growing middle class with disposable income is seeking aesthetic treatments, including hyperpigmentation therapies. The market is further stimulated by the introduction of innovative treatments and the growing awareness of skincare among Indian consumers. Additionally, the government's push towards improving healthcare infrastructure and the presence of international brands entering the Indian market is expected to accelerate the market's growth.

Latin America Hyperpigmentation Treatment Market Trends

Latin America's hyperpigmentation treatment market is expected to witness lucrative growth from 2024 to 2030. The increasing awareness about skincare and the growing demand for aesthetic treatments among the region's population are significant contributors to this growth. Additionally, the market is benefiting from the introduction of advanced treatment options, including lasers and topical medications, which are proving effective in managing pigmentation disorders. Economic stability in certain countries, coupled with the influx of international brands and the expansion of local businesses, is also playing a crucial role in boosting the market's growth.

The hyperpigmentation treatment market in Brazil is expected to grow due to the increasing prevalence of pigmentation disorders among the population, coupled with the rising demand for aesthetic treatments. The market is also being propelled by the introduction of innovative treatment options, such as lasers and topical medications, which are gaining popularity for their effectiveness in managing hyperpigmentation. Additionally, the economic stability in Brazil and the growing middle class with disposable income are contributing to the increased accessibility and affordability of these treatments, further stimulating market growth.

MEA Hyperpigmentation Treatment Market Trends

The MEA hyperpigmentation treatment market is expected to grow at a lucrative growth due to the growing population, increasing disposable income, and rising awareness about skincare and aesthetic treatments. However, the ongoing war in the region served as a significant restraining factor impacting this growth. The conflict disrupted supply chains, healthcare infrastructure, and access to treatment, leading to a potential slowdown in market expansion. Additionally, uncertainties and safety concerns due to the conflict resulted in a decrease in consumer spending on cosmetic treatments, further affecting market growth.

The hyperpigmentation treatment market in South Africa held the largest revenue market share in 2023. This is due to growing awareness about skin health and beauty standards, an increasing demand for cosmetic procedures, and a well-established healthcare infrastructure. Additionally, the availability of advanced treatment options and the presence of skilled dermatologists and healthcare professionals contribute to the market's growth in South Africa.

Key Hyperpigmentation Treatment Company Insights

The hyperpigmentation treatment market is experiencing substantial expansion, propelled by key companies broadening their service lines and incorporating cutting-edge technologies to secure a larger market presence and engage a broader audience. In May 2024, Regen Wellness introduced microneedling for healthy skin rejuvenation. Microneedling offers several benefits, including the treatment of acne scars, hyperpigmentation, and uneven skin texture, making it a versatile solution for various skin concerns.

Recent Developments

• In March 2024, L’Oréal Groupe launched Melasyl, a breakthrough molecule targeting localized pigmentation problems like age spots and post-acne marks. Melasyl-enhanced formulas are designed to be effective for all skin tones, improving overall appearance.

• In May 2024, The UltraClear fiber laser has received FDA clearance for two expanded indications in the hyperpigmentation treatment market, signaling its efficacy and safety for a broader range of skin conditions.

• In October 2022, Galderma introduced a new formulation in collaboration with Alastin Skincare, the A-Luminate Brightening Serum, designed to reduce the appearance of pigmentation. This launch highlights the companies' commitment to advancing hyperpigmentation treatment options.

• In March 2020, SkinCeuticals unveiled its Smart TCA Peel, a state-of-the-art trichloroacetic acid peeling system targeting all signs of aging with precision. This launch signifies SkinCeuticals' dedication to advancing hyperpigmentation treatment solutions.

Hyperpigmentation Treatment Market Report Scope

Report Attribute	Details
Market size value in 2024	USD 1.4 billion
Revenue forecast in 2030	USD 2.02 billion
Growth rate	CAGR of 6.4% from 2024 to 2030
Actual data	2018 - 2023
Forecast period	2024 - 2030
Quantitative units	Revenue in USD million/billion and CAGR from 2024 to 2030
Report coverage	Revenue forecast, company ranking, competitive landscape, growth factors, trends
Segments covered	By indication, treatment, skin tone, end-use, region
Regional scope	North America; Europe; Asia Pacific; Latin America; Middle East & Africa
Country scope	U.S.; Canada; Mexico; UK; Germany; France; Italy; Spain; Denmark; Sweden; Norway; Japan; China; India; Australia; South Korea; Thailand; Brazil; Argentina; South Africa; Saudi Arabia; UAE; Kuwait
Key companies profiled	Sedgh Plastic Surgery; Dermatologikum Berlin; Skin Deep Laser Services; Medical Beauty Cologne; Dermatology Private Clinic Dr. med; Aresu Naderi; The Harley Street Dermatology Clinic; Premier Laser Clinic UK Ltd.;, Qazi Cosmetic Center; ABBY SKIN CLINIC; The Marbella Vein & Beauty Clinic
Customization scope	Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Global Hyperpigmentation Treatment Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis on the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global hyperpigmentation treatment market report based on indication, treatment, skin tone, end-use, and region:

• Indication Outlook (Revenue, USD Million, 2018 - 2030)

  • Age spots

  • Melasma

  • Post-inflammatory hyperpigmentation (PIH)

  • Others

• Treatment Outlook (Revenue, USD Million, 2018 - 2030)

  • Energy-based Therapy

    • Laser

    • Intense Pulse Light (IPL)

    • Others

  • Chemical Peels

  • Microdermabrasion

  • Microneedling

• Skin Tone Outlook (Revenue, USD Million, 2018 - 2030)

  • Fitzpatrick skin type I & II

  • Fitzpatrick skin type III & IV

  • Fitzpatrick skin type V & VI

• End-use Outlook (Revenue, USD Million, 2018 - 2030)

  • Dermatology Clinics

  • Aesthetic Centers

  • Hospitals & Specialty Clinics

• Regional Outlook (Revenue, USD Million, 2018 - 2030)

  • North America

    • U.S.

    • Canada

    • Mexico

  • Europe

    • UK

    • Germany

    • France

    • Italy

    • Spain

    • Denmark

    • Sweden

    • Norway

  • Asia Pacific

    • Japan

    • China

    • India

    • Australia

    • South Korea

    • Thailand

  • Latin America

    • Brazil

    • Argentina

  • Middle East & Africa (MEA)

    • South Africa

    • Saudi Arabia

    • UAE

    • Kuwait